-
PLI scheme to help India become Aatmanirbhar in APIs; boost investments in high-value generics: ICRA
expresspharma
June 18, 2021
The production-linked incentive (PLI) schemes announced by the Government of India (GoI) for key raw materials such as bulk drugs and formulations, with a total incentive outlay of Rs. 210 billion will help the country become Aatmanirbhar.
-
Monosodium Phosphate 2-hydrate is now available with CEP
cphi-online
June 17, 2021
Dr. Paul Lohmann® recently received a CEP (Certificate of Suitability to the European Pharmacopoeia) for Monosodium Phosphate 2-hydrate, which enables a customer to register a drug in several countries in a cost-saving and simplified way.
-
Robust sales growth at Indian pharma companies expected in current FY on pandemic recovery, says Fitch
cphi-online
June 15, 2021
Drug categories impacted by travel restrictions expected to see higher sales levels in FY22
-
Entrinsic Bioscience Secures $49 million in Financing to Accelerate Development and Commercialization of Next Generation Functional Ingredients and Active Pharmaceutical Ingredients
firstwordpharma
June 11, 2021
entrinsic bioscience (EBS) announced that it has secured $49 million in non-dilutive growth capital from Jefferies Group LLC's subsidiary, Jefferies Funding LLC (Jefferies).
-
Novel microfluidic device could enhance crystalline drug safety
europeanpharmaceuticalreview
June 10, 2021
The continuous-flow microfluidic device allows scientists to assess crystalline API growth rates, shapes and structures to more quickly identify the best conditions for drug manufacturing.
-
Thermogelling nanoemulsion enhances drug loading of hydrophobic APIs
europeanpharmaceuticalreview
June 09, 2021
Using a new formulation technique, researchers were able to more than double drug loading of a hydrophobic active pharmaceutical ingredient in tablets. Thus, the new formulation method may lead to smaller pills delivering the same therapeutic benefit.
-
Onyx Scientific Receives Commercial API License for UK Facility
contractpharma
June 04, 2021
Onyx Scientific, a small molecule API contract development and manufacturing organization (CDMO) has received a commercial API license for its UK facility.
-
Biovectra Inc. Unveils New Logo and Brand
contractpharma
June 04, 2021
Biovectra Inc., a global contract development and manufacturing organization, has launched a new logo and brand to align with the growing company’s full suite of expertise and core values.
-
Sandoz outlines European antibiotic manufacturing expansion
cphi-online
May 20, 2021
Novartis generics and biosimilars division will invest €150 million during the next 3-5 years at its Kundl, Austria and Palafolls, Spain sites while phasing out production of oral APIs at Les Franqueses site
-
Colorcon Adds New Containment Suite in Its Global Headquarters
contractpharma
May 20, 2021
Colorcon, a leader in the development and supply of film coating systems and excipients, has expanded its technical service capabilities with a new Containment Suite located in its Global Headquarters in Harleysville, PA, USA.